SAM
EIGR
Simplify Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-90,000
| Closed | -$450K | – | 130 |
|
|
2024
Q1 | $450K | Buy |
+90,000
| New | +$450K | 0.03% | 82 |
|
|
2023
Q4 | – | Sell |
-2,700,000
| Closed | -$824K | – | 138 |
|
|
2023
Q3 | $824K | Buy |
2,700,000
+1,600,347
| +146% | +$488K | 0.09% | 69 |
|
|
2023
Q2 | $774K | Hold |
1,099,653
| – | – | 0.1% | 78 |
|
|
2023
Q1 | $986K | Buy |
+1,099,653
| New | +$986K | 0.14% | 53 |
|